Garamszegi N - Search Results

1

siRNA mediated inhibition of MMP-1 reduces invasive potential of a human chondrosarcoma cell line.

Jiang X, Dutton CM, Qi WN, Block JA, Garamszegi N, Scully SP. Jiang X, et al. Among authors: garamszegi n. J Cell Physiol. 2005 Mar;202(3):723-30. doi: 10.1002/jcp.20162. J Cell Physiol. 2005. PMID: 15499569

2

Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma.

Fong YC, Dutton CM, Cha SS, Garamszegi N, Sim FH, Scully SP. Fong YC, et al. Among authors: garamszegi n. Clin Cancer Res. 2004 Nov 1;10(21):7329-34. doi: 10.1158/1078-0432.CCR-04-0900. Clin Cancer Res. 2004. PMID: 15534109

3

Matrix metalloproteinase-1 contribution to sarcoma cell invasion.

Garamszegi N, Garamszegi SP, Scully SP. Garamszegi N, et al. J Cell Mol Med. 2012 Jun;16(6):1331-41. doi: 10.1111/j.1582-4934.2011.01402.x. J Cell Mol Med. 2012. PMID: 21801306 Free PMC article.

4

Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential.

Galoian KA, Garamszegi N, Garamszegi SP, Scully SP. Galoian KA, et al. Among authors: garamszegi n. Exp Biol Med (Maywood). 2007 Apr;232(4):515-22. Exp Biol Med (Maywood). 2007. PMID: 17392487

5

Extracellular matrix-induced gene expression in human breast cancer cells.

Garamszegi N, Garamszegi SP, Shehadeh LA, Scully SP. Garamszegi N, et al. Mol Cancer Res. 2009 Mar;7(3):319-29. doi: 10.1158/1541-7786.MCR-08-0227. Epub 2009 Mar 10. Mol Cancer Res. 2009. PMID: 19276183 Free PMC article.

6

Matrix metalloproteinase 1: role in sarcoma biology.

Jawad MU, Garamszegi N, Garamszegi SP, Correa-Medina M, Diez JA, Wen R, Scully SP. Jawad MU, et al. Among authors: garamszegi n. PLoS One. 2010 Dec 8;5(12):e14250. doi: 10.1371/journal.pone.0014250. PLoS One. 2010. PMID: 21170377 Free PMC article.

7

Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.

Garamszegi N, Garamszegi SP, Samavarchi-Tehrani P, Walford E, Schneiderbauer MM, Wrana JL, Scully SP. Garamszegi N, et al. Oncogene. 2010 Apr 22;29(16):2368-80. doi: 10.1038/onc.2009.514. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101206

8

Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.

Wilkes MC, Murphy SJ, Garamszegi N, Leof EB. Wilkes MC, et al. Among authors: garamszegi n. Mol Cell Biol. 2003 Dec;23(23):8878-89. doi: 10.1128/MCB.23.23.8878-8889.2003. Mol Cell Biol. 2003. PMID: 14612425 Free PMC article.

9

Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Penheiter SG, Mitchell H, Garamszegi N, Edens M, Doré JJ Jr, Leof EB. Penheiter SG, et al. Among authors: garamszegi n. Mol Cell Biol. 2002 Jul;22(13):4750-9. doi: 10.1128/MCB.22.13.4750-4759.2002. Mol Cell Biol. 2002. PMID: 12052882 Free PMC article.

10

Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells.

Doré JJ Jr, Yao D, Edens M, Garamszegi N, Sholl EL, Leof EB. Doré JJ Jr, et al. Among authors: garamszegi n. Mol Biol Cell. 2001 Mar;12(3):675-84. doi: 10.1091/mbc.12.3.675. Mol Biol Cell. 2001. PMID: 11251079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters